Benefits of using pump and sensor technology confirmed
Results from one of the largest studies of new diabetes management systems shows that using a combination of insulin pump and continuous glucose monitor results in significantly better long term blood glucose control compared to people using insulin injections alone.
Whilst it has long been known that insulin pump therapy can provide both a physical and psychological benefit to users, results from the recent Sensor-Augmented Pump Therapy for A1C Reduction trial (otherwise known as STAR 3) have shown that using an insulin pump in combination with a continuous glucose monitor can significantly reduce blood sugar fluctuations.
3 Comments 
JDRF funded trails at Cambridge University have shown that an artificial pancreas dramatically reduces the risk of potentially deadly hypoglycemia.
Two major JDRF-funded studies in the US have shown that continuous glucose monitors (CGMs) deliver better diabetes control with regular use for all age groups, while also reducing the frequency of hypoglycemia, or dangerously low blood glucose levels that can lead to coma or death.



